Archives
-
Levofloxacin Workflows for Resistance and Bone Assays
2026-09-29
Build mechanism-led bacterial susceptibility, plasmid-transfer, osteoblast, and cartilage assays with Levofloxacin (SKU B1959). This guide connects resistance surveillance to quantitative bone-cell readouts while emphasizing solubility control, orthogonal endpoints, and troubleshooting.
-
Anti-DYKDDDDK (Flag) Magnetic Beads Workflow
2026-09-29
Anti-DYKDDDDK (Flag) Magnetic Beads selectively capture DYKDDDDK-tagged fusion proteins from lysates and other complex samples for small-scale purification, immunoprecipitation, and co-immunoprecipitation. They are intended for accessible Flag-tagged targets, not for tag-free proteins, general protein enrichment, or unvalidated high-throughput workflows.
-
BOP Reagent for Peptide Prodrug Workflows
2026-09-28
BOP reagent provides a practical route for carboxyl group activation, direct amide bond formation, and phenyl ester preparation in modular peptide and prodrug synthesis. This guide translates that chemistry into assay-ready workflows inspired by a carrier-free, ROS-responsive OSCC prodrug study while clearly separating established specifications from optimization starting points.
-
Gastrin I: Linking Acid Secretion to GI Models
2026-09-28
Gastrin I (human) offers a defined way to probe CCK2-receptor-linked gastric acid secretion. This article explains how to use it in a compartment-aware research strategy alongside human intestinal organoids—without conflating gastric physiology with intestinal pharmacokinetics.
-
Lactate-Driven HMGB1 Modification in Sepsis
2026-09-27
The study links elevated lactate to HMGB1 lactylation and acetylation in macrophages, followed by exosomal release that can increase endothelial permeability. Its findings identify lactate-associated signaling as a candidate mechanism in polymicrobial sepsis, while leaving important questions about clinical translation and treatment specificity.
-
Azathramycin A: Ribosome Assays for TB Research
2026-09-26
Use Azathramycin A to investigate ribosome binding and bacterial protein synthesis inhibition in tuberculosis-focused research—not as a clinical treatment recommendation. This workflow pairs target-level assays with cautious cell-based follow-up, while accounting for solvent limits, solution instability, and the gap between a piglet PK/PD study and Mycobacterium tuberculosis research.
-
Cy3-UTP for RNA Delivery Assay Design
2026-09-25
Cy3-UTP can make RNA visible, but fluorescence alone cannot explain why a delivery system succeeds or fails. This article connects fluorescent RNA labeling to evidence on lipid nanoparticle surface charge and cellular V-ATPase activity, with practical guidance for separating uptake, intracellular processing, and RNA function.
-
Praeruptorin A Limits HCC Invasion Through ERK/MMP1
2026-09-25
A cell-based study found that praeruptorin A (PA) reduced migration and invasion in three human hepatocellular carcinoma cell lines without detectable cytotoxicity or cell-cycle changes. ERK knockdown reversed PA-associated MMP1 suppression and restored invasive behavior, supporting an ERK-dependent antimetastatic mechanism that remains to be tested in animal models and clinical settings.
-
FLAG tag Peptide for Native Membrane Complexes
2026-09-24
Learn how the FLAG tag Peptide (DYKDDDDK) can support isolation and analysis of native membrane-protein assemblies. A recent FtsH–HflK/C structural study shows why tag design, expression context, and gentle elution matter when interpreting complex architecture.
-
BRAF–NMDAR Signaling Drives Neuropathic Pain
2026-09-24
A 2026 study identifies BRAF in sensory neurons as a regulator of spinal NMDAR phosphorylation and synaptic hyperactivity after nerve injury. The results connect BRAF pathway activity to persistent pain behavior and suggest a potential therapeutic direction, while leaving clinical efficacy and the detailed signaling sequence to be established.
-
Bardoxolone methyl in Redox Assay Workflows
2026-09-23
Use Bardoxolone methyl to probe Nrf2 activation and NF-kB suppression, then pair pathway readouts with redox-sensitive replication-stress assays. This workflow distinguishes verified target engagement from a testable—but not yet established—effect on thioredoxin, ribonucleotide reductase, and CHK1-inhibitor response.
-
Fast-Dissociating Antibodies by Single-Molecule Screening
2026-09-23
Miyoshi and colleagues developed a semi-automated single-molecule TIRF assay that identifies specific, fast-dissociating monoclonal antibodies directly from hybridoma cultures. The resulting Fab probes supported multiplex super-resolution imaging and revealed rapid espin turnover within the long-lived F-actin cores of inner-ear stereocilia.
-
A Transient Conformation in the Adenine Riboswitch
2026-09-22
Wu et al. combined position-selective RNA labeling with stopped-flow fluorescence to resolve ligand-dependent conformational changes in the full-length adenine riboswitch. Their results identify an early, transiently unwound P1 helix before binding-pocket and P4 stabilization, refining the conventional view of riboswitch switching as a simple two-state process.
-
Canagliflozin and the Precision Metabolic Frontier
2026-09-22
Canagliflozin hemihydrate offers a focused way to investigate SGLT2-mediated renal glucose reabsorption while clarifying what the compound does not do. This thought-leadership perspective connects glucose metabolism research with drug-sensitized yeast mTOR screening, translating a negative TOR result into a practical strategy for assay design, mechanistic validation, and translational decision-making.
-
Pemetrexed: Designing DNA-Repair-Aware Assays
2026-09-21
Pemetrexed is more than a multi-target antifolate: it is a practical probe for connecting folate stress with DNA-repair phenotypes. This guide translates pemetrexed disodium pharmacology and mesothelioma evidence into better assay design and interpretation.